Khaw L E, Böhm G A, Metcalfe S, Staunton J, Leadlay P F
Cambridge Centre for Molecular Recognition and Department of Biochemistry, University of Cambridge, United Kingdom.
J Bacteriol. 1998 Feb;180(4):809-14. doi: 10.1128/JB.180.4.809-814.1998.
The gene rapL lies within the region of the Streptomyces hygroscopicus chromosome which contains the biosynthetic gene cluster for the immunosuppressant rapamycin. Introduction of a frameshift mutation into rapL by phiC31 phage-mediated gene replacement gave rise to a mutant which did not produce significant amounts of rapamycin. Growth of this rapL mutant on media containing added L-pipecolate restored wild-type levels of rapamycin production, consistent with a proposal that rapL encodes a specific L-lysine cyclodeaminase important for the production of the L-pipecolate precursor. In the presence of added proline derivatives, rapL mutants synthesized novel rapamycin analogs, indicating a relaxed substrate specificity for the enzyme catalyzing pipecolate incorporation into the macrocycle.
基因rapL位于吸水链霉菌染色体的一个区域内,该区域包含免疫抑制剂雷帕霉素的生物合成基因簇。通过phiC31噬菌体介导的基因置换在rapL中引入移码突变,产生了一个不产生大量雷帕霉素的突变体。该rapL突变体在添加了L-哌啶酸的培养基上生长,恢复了雷帕霉素生产的野生型水平,这与rapL编码一种对L-哌啶酸前体生产很重要的特定L-赖氨酸环脱氨酶的提议一致。在添加脯氨酸衍生物的情况下,rapL突变体合成了新型雷帕霉素类似物,表明催化哌啶酸掺入大环的酶具有宽松的底物特异性。